| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10211928 | Clinical Lymphoma Myeloma and Leukemia | 2018 | 32 Pages |
Abstract
These results suggest that mutational analysis findings will be invaluable for choosing an appropriate second-line tyrosine kinase inhibitor in Asia.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Hawk Kim, SooHyun Kim, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, Jae-Yong Kwak, Ho-Young Yhim, Sung-Hyun Kim, Young Rok Do, Sukjoong Oh, Sung-Eun Lee, Saengsuree Jootar, Jiu Wei Cui, Dong-Wook Kim,